International Clinical Trial: Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07136116) titled 'Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis' on Aug. 15.

Study Type: Observational

Primary Sponsor: AbbVie

Condition: Ulcerative Colitis

Recruitment Status: Not recruiting

Date of First Enrollment: August 27, 2025

Target Sample Size: 200

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07136116

Published by HT Digital Content Services with permission from Health Daily Digest....